RESUMO
BACKGROUND: Understanding the variances in visual skin changes across all skin tones is important in clinical care. However, the experiences of those teaching skin assessment to pre- and post-registrant nurses are unknown. AIMS: To determine the barriers and facilitators experienced in teaching skin assessment across a range of skin tones to pre- and post-registrant nurses. METHODS: A cross-sectional, mixed-methods online survey was undertaken throughout February and March 2023 based on the Theoretical Domains Framework of behaviour change. FINDINGS: In this self-selecting sample, most participants were aware of why it was important to include all skin tones when teaching skin assessment and were professionally motivated to include this in their practice. However, resources and support are needed to overcome an unconscious bias in teaching skin tone diversity, resulting in a lack of availability of good quality photographs and educator confidence in their own skills. Educators not considering skin tone when selecting patient cases and relying on people with dark skin tones to highlight where practice is not inclusive may also lead to insufficient exposure for students. CONCLUSION: There is some awareness of the importance of including diverse skin tones in teaching, but further education and resources are needed.
Assuntos
Higiene da Pele , Pigmentação da Pele , Humanos , Estudos Transversais , Estudantes , Inquéritos e QuestionáriosRESUMO
OBJECTIVES: Inflammatory bowel disease (IBD) imposes a significant burden on patients. The authors have noticed an underlying presence of distress, seemingly distinct from anxiety and depression, in qualitative data collected for previous studies. Disease-related distress has been explored in diabetes, but has not been addressed in IBD. The authors aimed to determine the presence of IBD distress to inform development of a scale for assessing the phenomenon. METHODS: This three-phase study used (1) a conceptual framework based on diabetes distress to conduct secondary analysis of qualitative data from four previous IBD studies (n=49 transcripts). Patient advisors confirmed the themes identified as causing distress, which guided (2) a focus group with people with IBD (n=8) and (3) items generated from phase 1 and 2 were subsequently used for a modified Delphi survey of IBD health professionals. RESULTS: Five IBD-distress themes were identified: emotional distress; healthcare-related distress; interpersonal/social distress; treatment-related distress; and symptom-related distress. DISCUSSION: Disease-specific distress in IBD was identified and is distinct from stress, anxiety and depression. Some causes of IBD distress overlap with diabetes distress, but existing diabetes-distress scales do not explain all the distress experienced by people with IBD and development of a new IBD-distress scale is warranted.
Assuntos
Ansiedade/psicologia , Efeitos Psicossociais da Doença , Depressão/psicologia , Doenças Inflamatórias Intestinais/psicologia , Estresse Psicológico/psicologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Grupos Focais , Humanos , Masculino , Pessoa de Meia-Idade , Pesquisa Qualitativa , Adulto JovemRESUMO
Clean intermittent self-catheterisation (CISC) is often a treatment option for women with urinary incontinence, particularly those with neurogenic bladder dysfunction. When used for appropriate patients it has been shown to promote continence and improve quality of life. There are a range of different products available on prescription for patients and many have been designed specifically with women in mind. Curan Lady is a new catheter that has recently been added to the UK NHS Drug Tariff. Patients suffering from limited/restricted mobility in their hands, found the Curan Lady easy to open and use. CISC can promote privacy and dignity for women with urinary incontinence and patient choice regarding product selection is important. Nurses need to keep up to date with new product availability for patients in order to offer choice to women performing CISC.
Assuntos
Cateterismo Uretral Intermitente/instrumentação , Qualidade de Vida , Incontinência Urinária/terapia , Adulto , Idoso , Idoso de 80 Anos ou mais , Desenho de Equipamento , Feminino , Humanos , Cateterismo Uretral Intermitente/efeitos adversos , Educação de Pacientes como Assunto , Satisfação do Paciente , Autocuidado , Avaliação da Tecnologia Biomédica , Bexiga Urinaria Neurogênica/terapiaRESUMO
BACKGROUND AND AIMS: Testing for LTBI is recommended prior to anti-TNFα agents. This includes an assessment of TB risk factors, chest radiograph, and interferon-gamma release assay alone or with concurrent Tuberculin skin testing. Here we review our experience and cost-effectiveness of using T-SPOT.TB IGRA to detect mycobacterial infection in patients with IBD suitable for anti-TNFα therapy. METHODS: This was a single-centre, retrospective review and economic evaluation (compared to British Thoracic Society guidance) of 125 adult IBD patients (90 anti-TNFα naïve, 35 established on anti-TNFα) tested for LTBI using T-SPOT.TB IGRA. RESULTS: All subjects had normal chest radiographs and no clinical evidence for TB. 109 (87%) were BCG vaccinated. 27 (22%) of all patients tested were not using immunomodulation at the time of testing. 66 (53%) were taking thiopurines, 22 (18%)corticosteroids, and 35 (28%) anti-TNFα agents. One hundred twenty two (98%) had a negative IGRA result, two (2%) had positive results, and one (1%) had an indeterminate IGRA. A strategy using IGRA to guide TB preventative treatment produced cost savings of £10.79 per person compared to the BTS guidance. Eighty eight percent of the anti-TNFα naïve group have subsequently received treatment with either infliximab or adalimumab (median follow-up of 24 months, IQR 18-30) with no cases of TB disease occurring. CONCLUSIONS: The use of a simple screening protocol for LTBI incorporating T-SPOT.TB IGRA in place of TST in a largely BCG vaccinated population, many using immunomodulatory agents, appears to work well and is a cost-effective strategy in our IBD service.
Assuntos
Imunossupressores/uso terapêutico , Doenças Inflamatórias Intestinais/tratamento farmacológico , Testes de Liberação de Interferon-gama , Tuberculose Latente/diagnóstico , Fator de Necrose Tumoral alfa/antagonistas & inibidores , Adalimumab , Corticosteroides/uso terapêutico , Adulto , Anticorpos Monoclonais/uso terapêutico , Anticorpos Monoclonais Humanizados/uso terapêutico , Azatioprina/uso terapêutico , Análise Custo-Benefício , Feminino , Humanos , Doenças Inflamatórias Intestinais/complicações , Infliximab , Testes de Liberação de Interferon-gama/economia , Tuberculose Latente/complicações , Masculino , Mercaptopurina/uso terapêutico , Pessoa de Meia-Idade , Estudos Retrospectivos , Reino UnidoRESUMO
Older people, particularly those with underlying health problems, commonly experience constipation, which is a distressing symptom that can adversely affect quality of life. Assessment of constipation is vital to exclude treatable and underlying conditions and a step-wise approach should be taken to managing chronic constipation in older people. Lifestyle modification and laxatives remain the mainstay of constipation management, but newer interventions are being developed and applied to the care of older people. Nurses are often pivotal to the identification and successful management of constipation. They should ensure that their knowledge and skills are maintained to enable them to implement care that is effective and evidence based.